IFIS: Information on medicines, the risks of failure to provide information and responsibilities in case of failure

Join Aude VIDAL on 29 September for the IFIS - Institut de Formation des Industries de Santé training course on the risks linked to the lack of information, the responsibilities of manufacturers and the authorities in the event of failure.

At the heart of the news, the risks linked to product information are driving the judicial and media debate, as shown by the recent indictment of the ANSM in the context of the Levothyrox case.

This training is an opportunity to review the regulatory framework for medicines information, to understand the specificities of risk communication and to know the risks (criminal, civil, regulatory).